Monte Rosa Therapeutics (GLUE) Tax Provisions (2023 - 2026)
Monte Rosa Therapeutics' (GLUE) quarterly Tax Provisions came in at $100000.0 in Q1 2026, down 87.83% year-on-year from $822000.0 in Q1 2025, and up 69.49% quarter-over-quarter from $59000.0 in Q4 2025.
Monte Rosa Therapeutics (GLUE) Tax Provisions (2023 - 2026) Analysis & Trends
Monte Rosa Therapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 87.83% year-over-year to $100000.0 in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 87.0% increase from a year earlier, with the FY2025 full-year figure at -$1.1 million, up 92.55% from the prior year.
- Tax Provisions climbed to $100000.0 in Q1 2026 per GLUE's latest filing, from $59000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1.2 million in Q2 2025 and bottomed at -$15.1 million in Q4 2024.
- The 4-year median for Tax Provisions is $100000.0 (2024), against an average of -$1.3 million.
- Across the five-year window, Tax Provisions sank 68686.36% in 2024 and jumped 722.0% in 2025, its largest moves.
- Year by year, Tax Provisions stood at -$22000.0 in 2023, then sank by 68686.36% to -$15.1 million in 2024, then jumped by 100.39% to $59000.0 in 2025, then soared by 69.49% to $100000.0 in 2026.
- Per Business Quant, the three latest GLUE Tax Provisions figures stand at $100000.0 (Q1 2026), $59000.0 (Q4 2025), and -$3.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Monte Rosa Therapeutics | 2.30 Bn | 1.62 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 822,000.00 |
| Dec 31, 2024 | -15.13 Mn |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 252,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | 170,000.00 |
| Jun 30, 2023 | 190,000.00 |